PT510773E - Vacina subunidade do coronavirus canino - Google Patents
Vacina subunidade do coronavirus caninoInfo
- Publication number
- PT510773E PT510773E PT92201136T PT92201136T PT510773E PT 510773 E PT510773 E PT 510773E PT 92201136 T PT92201136 T PT 92201136T PT 92201136 T PT92201136 T PT 92201136T PT 510773 E PT510773 E PT 510773E
- Authority
- PT
- Portugal
- Prior art keywords
- subunit vaccine
- ccv
- coronavirus
- spike protein
- protein
- Prior art date
Links
- 241000282465 Canis Species 0.000 title 1
- 241000711573 Coronaviridae Species 0.000 title 1
- 229940031626 subunit vaccine Drugs 0.000 title 1
- 241000711506 Canine coronavirus Species 0.000 abstract 4
- 229940096437 Protein S Drugs 0.000 abstract 3
- 101710198474 Spike protein Proteins 0.000 abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 238000010353 genetic engineering Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229940126580 vector vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91303737 | 1991-04-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT510773E true PT510773E (pt) | 2004-04-30 |
Family
ID=8208264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT92201136T PT510773E (pt) | 1991-04-25 | 1992-04-22 | Vacina subunidade do coronavirus canino |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5661006A (pt) |
| EP (1) | EP0510773B1 (pt) |
| JP (1) | JP3420258B2 (pt) |
| AT (1) | ATE256746T1 (pt) |
| AU (1) | AU645417B2 (pt) |
| CA (1) | CA2066940C (pt) |
| DE (1) | DE69233270T2 (pt) |
| DK (1) | DK0510773T3 (pt) |
| ES (1) | ES2213743T3 (pt) |
| NZ (1) | NZ242471A (pt) |
| PT (1) | PT510773E (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6372224B1 (en) | 1990-11-14 | 2002-04-16 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
| US6057436A (en) * | 1990-11-14 | 2000-05-02 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
| US5484719A (en) | 1991-08-26 | 1996-01-16 | Edible Vaccines, Inc. | Vaccines produced and administered through edible plants |
| US6034298A (en) * | 1991-08-26 | 2000-03-07 | Prodigene, Inc. | Vaccines expressed in plants |
| US5612487A (en) * | 1991-08-26 | 1997-03-18 | Edible Vaccines, Inc. | Anti-viral vaccines expressed in plants |
| JP3245169B2 (ja) * | 1992-05-08 | 2002-01-07 | ファイザー・インコーポレイテッド | イヌ・コロナウイルスｓ遺伝子およびその使用 |
| US20020195417A1 (en) * | 2001-04-20 | 2002-12-26 | Steinberg Dan A. | Wet and dry etching process on <110> silicon and resulting structures |
| GB0217434D0 (en) | 2002-07-27 | 2002-09-04 | Royal Vetinary College | Biological material |
| US6772918B2 (en) * | 2002-10-07 | 2004-08-10 | Justrite Manufacturing Company | Safety can |
| US8080642B2 (en) * | 2003-05-16 | 2011-12-20 | Vical Incorporated | Severe acute respiratory syndrome DNA compositions and methods of use |
| US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| GB0315323D0 (en) * | 2003-07-01 | 2003-08-06 | Royal Veterinary College | Vaccine composition |
| EP1780216B1 (en) * | 2005-10-26 | 2010-12-29 | Canio Buonavoglia | Pantropic canine coronavirus |
| US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| CN112301153B (zh) * | 2020-02-06 | 2023-09-08 | 广州普世君安生物科技有限公司 | 一种快速检测犬冠状病毒（ccv）的rda方法及试剂盒 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) * | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4722848A (en) * | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US4470967A (en) * | 1982-10-05 | 1984-09-11 | Iowa State University Research Foundation | Lectin-containing anti-viral vaccines for domestic animals and method of preparation |
| US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
| EP0138242A1 (en) * | 1983-09-07 | 1985-04-24 | Duphar International Research B.V | Method of preparing DNA complementary to the genome of coronaviruses |
| HUT45559A (en) * | 1987-01-16 | 1988-07-28 | Duphar Int Res | Process for producing new proteines and peptides of antigene activity and vaccines against virus of infective gastritis-enteritis |
| US4904468A (en) * | 1987-06-08 | 1990-02-27 | Norden Laboratories, Inc. | Canine coronavirus vaccine |
| CA2005291C (en) * | 1988-12-30 | 1999-01-26 | Beverly Dale | Feline infectious peritonitis virus diagnostic tools |
| US5202430A (en) * | 1990-01-16 | 1993-04-13 | University Of Tennessee | Transmissible gastroenteritis virus genes |
| GB9001766D0 (en) * | 1990-01-25 | 1990-03-28 | Univ Court Of The University O | Vaccines |
| EP0524672A1 (en) * | 1991-06-27 | 1993-01-27 | Duphar International Research B.V | CCV vaccine |
| GB9203509D0 (en) * | 1992-02-19 | 1992-04-08 | British Tech Group | Ibv spike protein(2) |
-
1992
- 1992-04-22 AT AT92201136T patent/ATE256746T1/de not_active IP Right Cessation
- 1992-04-22 ES ES92201136T patent/ES2213743T3/es not_active Expired - Lifetime
- 1992-04-22 PT PT92201136T patent/PT510773E/pt unknown
- 1992-04-22 DK DK92201136T patent/DK0510773T3/da active
- 1992-04-22 DE DE69233270T patent/DE69233270T2/de not_active Expired - Lifetime
- 1992-04-22 EP EP92201136A patent/EP0510773B1/en not_active Expired - Lifetime
- 1992-04-23 NZ NZ242471A patent/NZ242471A/xx not_active IP Right Cessation
- 1992-04-23 CA CA002066940A patent/CA2066940C/en not_active Expired - Lifetime
- 1992-04-24 AU AU15131/92A patent/AU645417B2/en not_active Ceased
- 1992-04-24 JP JP10708392A patent/JP3420258B2/ja not_active Expired - Fee Related
-
1994
- 1994-09-19 US US08/308,872 patent/US5661006A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2213743T3 (es) | 2004-09-01 |
| AU645417B2 (en) | 1994-01-13 |
| JP3420258B2 (ja) | 2003-06-23 |
| DE69233270D1 (de) | 2004-01-29 |
| US5661006A (en) | 1997-08-26 |
| JPH05260976A (ja) | 1993-10-12 |
| DK0510773T3 (da) | 2004-04-19 |
| CA2066940C (en) | 2003-10-21 |
| CA2066940A1 (en) | 1992-10-26 |
| DE69233270T2 (de) | 2004-09-30 |
| NZ242471A (en) | 1993-05-26 |
| EP0510773A1 (en) | 1992-10-28 |
| AU1513192A (en) | 1992-10-29 |
| ATE256746T1 (de) | 2004-01-15 |
| EP0510773B1 (en) | 2003-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT510773E (pt) | Vacina subunidade do coronavirus canino | |
| DK157087D0 (da) | Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus | |
| DE60012711D1 (de) | Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe | |
| BR0113109A (pt) | Anticorpos antil-il-12, composições, métodos e usos | |
| GR3017770T3 (en) | Feline infectious peritonitis virus diagnostic tools. | |
| DE3882599D1 (de) | Hundecoronavirus-impfstoff. | |
| DK0652287T3 (da) | Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom | |
| DK0653489T3 (da) | Coccidiosisvaccine til fjerkræ | |
| DE69203950T2 (de) | Rekombinanter Impfstoff gegen Marek's Krankheit. | |
| DE68909041D1 (de) | Eimeria tenella-Vakzin. | |
| DK0485463T3 (da) | Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde | |
| Morgan et al. | Recombinant vaccine against Marek's disease | |
| ATE460945T1 (de) | Genetische adjuvanz-impfstoffe |